IDWeek 2012

At IDWeek 2012, researchers presented that the addition of azithromycin to ceftriaxone therapy for children hospitalized with community-acquired pneumonia (CAP) was not associated with differences in length of stay.

Presidents of the four respective organizations comprising IDWeek welcomed more than 6,500 attendees—including 795 fellows and 200 residents—to the first joint meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS).